Interpace Diagnostics Group(DE:PF4)
€6.400.00 (0.00%)
DE:PF4
Interpace Diagnostics Group financials statements
€6.40
At close:0.00 (0.00%)
Interpace Diagnostics Group (PF4) Income Statement
0 Followers
Interpace Diagnostics Group Income Statement
Last quarter (Q2 2026), Interpace Diagnostics Group's total revenue was $9.13M, a decrease of 1.09% from the same quarter last year. In Q2, Interpace Diagnostics Group's net income was $158.00K. See Interpace Diagnostics Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| $ 38.73M | $ 46.93M | $ 40.21M | $ 31.84M | $ 41.31M | |
| $ 24.13M | $ 29.93M | $ 23.90M | $ 18.23M | $ 17.95M | |
| $ 20.05M | $ 21.82M | $ 21.10M | $ 22.07M | $ 29.68M | |
| Depreciation and Amortization | $ 821.00K | $ 748.00K | $ 1.60M | $ 2.56M | $ 5.37M |
| $ 4.76M | $ 8.36M | $ 4.41M | $ -2.27M | $ -1.33M | |
| $ 4.08M | $ 8.11M | $ 2.80M | $ -3.84M | $ -11.74M | |
| $ -310.00K | $ -1.16M | $ -1.68M | $ -2.22M | $ -1.41M | |
| $ 3.77M | $ 6.95M | $ 1.13M | $ -5.84M | $ -15.41M | |
| $ 24.57M | $ 6.70M | $ 802.00K | $ -5.87M | $ -14.75M | |
| Per Share Metrics | |||||
| Basic EPS | $ 27.75 | $ 7.10 | $ 0.95 | $ -6.90 | $ -17.85 |
| Diluted EPS | $ 4.45 | $ 2.00 | $ 0.90 | $ -6.90 | $ -17.85 |
| Weighted Average Shares Outstanding | 884.80K | 877.40K | 863.40K | 847.60K | 827.00K |
| Weighted Average Shares Outstanding (Diluted) | 5.54M | 877.40K | 872.80K | 847.60K | 827.00K |
Currency in USD
